Sanofi
Long-Acting Formulations of Insulin
Last updated:
Abstract:
The application relates to an aqueous pharmaceutical formulation comprising 200-1000 U/mL [equimolar to 200-1000 IU human insulin] of insulin glargine.
Status:
Application
Type:
Utility
Filling date:
16 Feb 2021
Issue date:
7 Oct 2021